Lesage Anne
Lesage Anne, CED, reported an open-market or private sale at Pharvaris N.V. involving 20000.000000 shares for an estimated $765466.00. Reported holdings after the transaction were 73969.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 17, 2026
- Filing date
- Sep 21, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 93,969 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
PHVS price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001193125-26-396572 Common Stock
- Transaction date
- Sep 17, 2026 Filed Sep 21, 2026, 07:13 PM · 4d delay
- Shares
- 20,000 sh $38.27 per share
- Estimated value
- -$765k Computed from shares × price
- Holdings after
- 73,969 sh Indirect · By GrayMatters Consulting BVBA
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Early Development
- F1
The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a ca…
- F2
GrayMatters Consulting B.V., an entity controlled by Dr. Lesage
0 other transactions
0 recent txs